Covance Honolulu CRU — Honolulu, Hawaii

Covance Honolulu CRU is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Covance Honolulu CRU has participated in 1 clinical trials.

Therapeutic areas: Aldehyde Dehydrogenase-2 (ALDH2) Deficiency.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Covance Honolulu CRU?

Covance Honolulu CRU has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Covance Honolulu CRU conducted?

Covance Honolulu CRU has 1 clinical trials on record. Their work covers Aldehyde Dehydrogenase-2 (ALDH2) Deficiency.

Is Covance Honolulu CRU accredited by Crixeo Health?

Covance Honolulu CRU has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Covance Honolulu CRU?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.